Supply Issue Medtronic Ltd Hysteroscope FTX039 (ICN 2647)

• The supply issue with Hysteroscope products from Medtronic Ltd is continuing.
• One product code remains affected in total:
  • FTX039 – Hysteroscopic Fibroid Truclear ultra plus device.
• The affected product code is no longer being demand managed by the supplier but is now unavailable to order.
• Unfortunately, there are no alternatives available. Customers are advised to view the online catalogue for products they deem suitable.
• See our Downloads ▼ section to access the product listing for further information on the affected product code.
• The supply issue is now anticipated to be resolved by 1 May 2025.

Change:

• The supplier Medtronic Ltd has informed us of a supply issue with its Hysteroscope products:
  • FTX039 – Hysteroscopic Fibroid Truclear ultra plus device.
• The supply issue is due to raw material shortage which has caused a backlog of orders.

Impact:

• Medtronic is demand managing this product to reduce back orders and maintain supply.
• FTX039 is still available to order on an intermittent supply basis.
• Unfortunately, there are no alternatives available. Customers are advised to view the online catalogue for products they deem suitable.
• See our Downloads ▼ section to access the product listing for further information on the affected product code.
• The supply issue is anticipated to be resolved by 31 December 2024.

Next Steps:               

• Customers are advised to log into our website to view the product listing for further information on the affected product code.
• Customers will need to consider alternative sizes within the TruClear tissue shaver range. For system compatibility reasons alternative brands of uterine tissue removal shaver are not advised.
• Please consult your clinical experts for advice on suitability of the suggested sizes and tip types within the TruClear tissue shaver range.
• The continuing supply issue is being monitored in conjunction with the supplier and we will continue to review the stock situation to minimise further disruption and update this ICN with the latest information as it becomes available.
• If you have any further questions, please contact your local NHS Supply Chain Customer Services Advisor.

Please note that due to the clinical nature of these alternative products, we advise you to consult your own clinical experts to ensure suitability for your organisations use of these products.